FDA Law

JANUARY 12, 2025

Lastly, the reforms enacted by FDORA required that FDA publish guidance on early consultation with FDA to identify novel surrogate or intermediate clinical endpoints, use of novel trials designs for postapproval studies, the expedited withdrawal procedures, and considerations related to the use of surrogate and intermediate clinical endpoints.

Clinic 64

Clinic Relationship Provider IT 64

Today's Hospitalist

JUNE 7, 2025

“You want someone who can monitor patients’ side effects and have a longitudinal relationship with them.” Laudenslager, is a chronic metabolic disease with highly complex pathophysiology—”and we are programmed to regain the weight we lose with lifestyle measures.”

Hospital 63

Hospital Management Diabetes Patients 63

GeriPal

AUGUST 1, 2024

Widera and Smith have no relationships to disclose. Guests Anna Pleet, Elizabeth Eckstrom, and Emily Johnston have no relationships to disclose. So if you already have a condition, you might be able to prevent events. The time it takes to look at chronic disease prevention or outcomes is just, it’s in the word chronic.

IT 116

IT Diabetes Chronic Disease Patient-Centered 116